Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases

NCT02314026 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT02314026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Lead sponsor
Meridian Bioscience, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2017
Enrollment
140 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis